CMO Job Description | Life Sciences Executive Search

Chief Medical Officer Job Description: International Biotech & Pharm

CMO Compensation Benchmarks — U.S. Market (2024–2025)

Sources: Mercer, Korn Ferry, Salary.com (2024–2025 data)

What a Chief Medical Officer Actually Does

The Chief Medical Officer job description often gets written as though the role were a clinical advisory position. That's wrong. A CMO is an executive — someone who owns medical strategy, builds teams, manages budgets, and reports directly to the CEO or President.

Core responsibilities typically include:

Clinical development strategy: Defining the evidence package needed for each indication, selecting trial design, scoping endpoint selection, and building the clinical development plan.

Regulatory affairs coordination: Partnering with the Head of Regulatory Affairs to prepare FDA submissions, lead pre-submission meetings, and ensure all clinical data align with regulatory strategy. This is especially critical in pharmaceutical recruiting where regulatory expertise often determines competitive advantage.

Medical affairs leadership: Building and directing the medical affairs function, including medical information, speaker programs, key opinion leader engagement, and field-based medical liaisons.

Physician relationships: Serving as the clinical voice to key opinion leaders, hospital systems, and physician networks — both pre- and post-launch.

Risk management: Ensuring pharmacovigilance systems are reliable, adverse event monitoring is rigorous, and the organization can respond credibly to safety signals.

Cross-functional strategy: Partnering with R&D, Commercial, and Quality to translate clinical data into go/no-go decisions, label claims, and market positioning.

Competitive intelligence: Monitoring competitive clinical data, understanding where your assets sit relative to competitors, and identifying white space.

Many CMOs also oversee Clinical Operations — the logistics of running trials, site management, and data management. Others hold the interim CFO title at smaller companies or wear a commercial role until the company grows. The specific Chief Medical Officer job description should clarify these boundaries.

Chief Medical Officer Job Description: Key Structural Elements

A functional job description does four things: it defines the role's mission, outlines major responsibilities, specifies required qualifications, and signals the company's values. Here's the anatomy:

Role Title & Reporting Line: State this clearly. "Chief Medical Officer" reports to the CEO or President. If the CMO will report to a Chief Commercial Officer or Head of R&D, say so — but the CEO title signals C-suite independence.

Scope & Accountability

Specify what medical functions roll up to the CMO. Example: "You will oversee clinical development, medical affairs, medical information, and pharmacovigilance. You will collaborate with Regulatory Affairs but do not directly supervise that function." This prevents scope confusion later. Clarity on scope is essential when building teams, especially in medical device recruiting or pharma where medical and regulatory functions intersect.

Primary Responsibilities

List 6–8 major responsibility blocks, not 20-item checklists. Block-level thinking invites strategic ownership; bullet overload makes the role feel tactical. For example:

• Clinical Development Leadership: Own the clinical development strategy across all programs. Define endpoints, trial designs, and go/no-go criteria for each indication. Partner with Chief Scientific Officer on translational science; partner with Regulatory on submission planning.
• Regulatory Strategy & Submission Leadership: Lead the preparation of all regulatory submissions (IND, BLA/NDA, amendments). Conduct pre-submission meetings with FDA. Ensure the clinical evidence package supports all proposed claims and labeling language.
• Medical Affairs & KOL Relationships: Build and lead the medical affairs function, including speaker development, scientific meetings, and KOL engagement. Establish yourself as the credible clinical voice for the company's pipeline.
• Product Safety & Pharmacovigilance: Oversee pharmacovigilance systems, adverse event monitoring, and safety reporting. Ensure the organization can respond to safety signals credibly and in real time.

Cross-Functional Strategy: Collaborate with R&D, Commercial, and Quality to translate clinical insights into product strategy, pricing strategy, and launch planning.

Required Qualifications

Be specific. Generic lists ("10+ years of pharma experience") don't screen for quality. Instead:

• MD, DO, or equivalent medical degree required.
• Minimum 12 years of progressive medical leadership in pharma/biotech; at least 5 years in a medical officer or medical director role with P&L accountability.
• Demonstrated success leading clinical trials in your disease area (oncology, cardiology, rare disease, etc.). Show evidence of thinking — published data, regulatory approvals — not just roles held.
• Fluency with FDA processes: IND/NDA/BLA submissions, Type B/C meetings, expedited pathways (Breakthrough, Fast Track). Don't just claim familiarity; describe a specific submission you led.
• Experience building and scaling medical affairs teams; ability to recruit, develop, and retain talent.
• Strategic mindset: You must translate science into go/no-go decisions, defend those decisions to investors and boards, and adapt when data surprise you.

Avoid redundant or vague phrases. "Strong communication skills" adds nothing. Instead: "Must articulate clinical strategy to non-clinical stakeholders (investors, boards, commercial leaders) and defend those positions under pressure."

Preferred Qualifications

This is where you signal nice-to-have domain depth or geography. Examples:

• Prior experience in your specific indication area (e.g., "Experience with rare genetic disorders and RNA therapeutics preferred").
• International regulatory experience (EU/EMA, PMDA) or experience hiring for or managing globally distributed teams.
• Track record launching products in competitive markets.

CMO Role Responsibilities Across Company Stage

The Chief Medical Officer job description should scale with company stage. A CMO at a Series B company with two Phase 2 programs faces a very different mandate than a CMO at a late-stage company with an approved product and a pipeline of line extensions.

Early-Stage Biotech (Series A/B, Pre-IND)

The CMO at this stage is part founder-advisor, part strategist, part operator. The clinical development plan is the company's north star.

Typical responsibilities:

• Distill the preclinical program into a credible IND-enabling package; partner with the Chief Scientific Officer to design first-in-human studies.
• Recruit and mentor a small medical affairs team or hire a part-time medical affairs consultant.
• Attend investor meetings to articulate clinical rationale and de-risk the program.
• Build relationships with key opinion leaders and potential site networks.
• Establish pharmacovigilance procedures (yes, even for Phase 1).

Typical salary range: $250,000–$350,000 all-in (base + equity, depending on location, degree, and prior experience). Equity stakes are meaningful — 10–20 basis points on a Series A capitalization are not unusual.

Mid-Stage Biotech (Series C/D, Phase 2/3)

The organization is maturing. There are now multiple programs, a formal regulatory pathway, and investor expectations for timely approvals.

Typical responsibilities:

• Own the clinical development plan for 2–3 programs; ensure Phase 2/3 trials are designed to support registration and payer discussions.
• Build a medical affairs team (3–6 people) with medical information specialists, medical liaisons, and perhaps a Director of Medical Affairs.
• Conduct pre-submission meetings with FDA; partner with Head of Regulatory on NDA strategy.
• Begin health economics work to support market positioning and payer discussions.
• Establish competitive intelligence systems; track competitor clinical data.

Typical salary range: $350,000–$500,000 all-in (base + equity). Equity is still a meaningful part of comp but smaller on a larger cap table. Stock options are now vesting over 4 years with a 1-year cliff.

Late-Stage Biotech / Commercial Biotech (Series E+, Approved Product(s))

The company has an approved product or is in final NDA review. The medical function is now scaled and commercial success depends partly on how well medical affairs executes.

Typical responsibilities:

• Oversee clinical development for approved indications and line extensions (new formulations, patient populations, combinations).
• Lead the medical affairs function as a revenue-supporting function — speaker programs, advisory boards, field insights.
• Partner with Commercial on launch planning, sales force training, and promotional claim substantiation.
• Build the competitive medical intelligence system; update competitive positioning quarterly.
• Ensure ongoing safety monitoring and real-world evidence generation.

Typical salary range: $500,000–$750,000 + annual bonus. Base salaries at this stage often include 15–25% performance bonuses tied to regulatory milestones, product launches, or clinical data readouts.

Pharma-Backed Subsidiary or Joint Venture (Foreign Parent, US Operations)

This is the unique context for many of Pact & Partners' clients. A European or Asian pharmaceutical company has acquired or founded a US subsidiary and needs to hire local talent. The CMO role is critical because the parent company's medical strategy and regulatory expertise must translate into US-market operations.

Unique challenges for this CMO:

• Managing expectations from a non-US parent company accustomed to EMA timelines, EMA interactions, and different medical affairs traditions.
• Ensuring US clinical development feeds into global development plans and regulatory submissions.
• Building a US medical affairs team that complements (not duplicates) the parent company's medical structure.
• Translating global medical strategy into US-specific regulatory and commercial execution.

When writing the Chief Medical Officer job description for this context, clarify reporting lines. Does the CMO report to the US subsidiary CEO or to the parent company's Chief Medical Officer? (Usually the former, with a dotted line to the latter.) Does the US CMO lead US-only strategy or have input on global strategy?

How to Hire a Chief Medical Officer USA: Key Mistakes to Avoid

Mistake #1: Confusing CMO with Chief Scientific Officer

The Chief Scientific Officer owns the science — target validation, drug discovery, preclinical work, translational strategy. The CMO owns the clinical evidence and regulatory strategy to move that science to patients. They must work closely, but their job descriptions should be distinct.

If you conflate them, you often hire a brilliant researcher who has no interest in regulatory timelines or commercial constraints. You'll regret this when critical FDA meeting decisions need to be made and the CMO-CSO hasn't the bandwidth or inclination.

Mistake #2: Underspecifying Regulatory Experience

Many organizations write "Experience with FDA processes" and call it sufficient. This creates disasters. A CMO must have hands-on IND and NDA experience — not just observation. Ask:

• How many INDs have you filed? For what indications? What did you learn?
• Tell me about a Type B or Type C meeting with FDA. What was the question? How did you prepare? What was the outcome?
• Have you navigated an Accelerated Approval or Breakthrough designation? If so, what were the post-approval commitments?

If the candidate hemms and haws, they don't have the depth you need. Regulatory credibility is the CMO's currency with FDA and with your board.

Mistake #3: Hiring for Pedigree, Not Track Record

A CMO from Merck or Roche isn't automatically better than one from a smaller biotech — and may be worse. Large pharma CMOs often inherit strong infrastructure (regulatory, medical affairs, clinical ops) and mistake that for personal competence. At a small company, that CMO will drown.

Evaluate track record, not brand. Can the candidate point to a program they personally drove from Phase 1 to approval? Have they built a team from scratch? Have they managed budget constraints and pivoted when data were disappointing?

Mistake #4: Underestimating the Importance of Physician Credibility

A CMO must command respect from physicians — internal KOLs, FDA medical reviewers, hospital networks, even patients. If the candidate has no published data, limited speaking history, or a record of defensive rather than thoughtful science communication, they'll struggle.

Look for evidence of publication history, speaking invitations at major medical meetings, and reputation in the disease community. These signals matter more than credentials.

Mistake #5: Overlooking International Regulatory Experience

If your company operates or aspires to operate in Europe, Asia, or other regions, the CMO should understand non-US regulatory pathways. EMA approval timelines, PMDA interactions, or Health Canada processes differ from FDA. A CMO who understands only US pathways will create strategic misalignment.

When writing the Chief Medical Officer job description for a foreign-owned company hiring in the US through Miami executive recruiters or Boston executive recruiters, clarify what international involvement is expected. If the CMO will coordinate with a European medical team, say so.

Mistake #6: Hiring Someone Without Commercial Awareness

Some CMOs see themselves as purely clinical voices, divorced from commercial realities. This is a luxury companies can no longer afford. Your CMO must understand pricing, reimbursement, and competitive positioning. They don't need to set price, but they must help Commercial understand what the data support.

During interviews, ask: "How have you worked with Commercial? Tell me about a situation where you disagreed with the Commercial strategy and how you resolved it." Answers reveal whether the candidate operates in a silo or as part of the broader leadership team.

CMO Compensation by Stage: Benchmarks & Negotiation

Compensation for a Chief Medical Officer job description varies significantly by stage, geography, degree specialty, and prior achievements. Here's a realistic breakdown:

The table above reflects industry benchmarks across company stages. Compensation structures differ by stage: early-stage companies rely heavily on equity to bridge lower base salaries, while late-stage and public biotech emphasize cash and performance bonuses. Pharma subsidiaries often mirror parent company pay bands, adjusted for local market conditions.

These figures assume an MD/DO in a major biotech hub (Boston, San Francisco, San Diego). Add 10–20% if the candidate has published clinical data, founded a company, or led a regulatory approval. Subtract 10–15% for earlier-career candidates or those without publications.

Key negotiation points:

• Clawback provisions: Does the company claw back bonus if a major trial fails? Some candidates resist aggressive clawbacks; others accept them as aligned risk.
• Severance: Most CMOs negotiate 12 months' severance + continued vesting if terminated without cause. Don't accept less than 6 months unless the equity package is exceptional.
• Sign-on bonus: Early-stage companies often offer $50,000–$150,000 to offset leaving equity behind at prior employers.
• Relocation assistance: If hiring from abroad, budget $30,000–$50,000 for relocation, visa sponsorship, and legal support.

Crafting the Ideal Chief Medical Officer Job Description: A Template

Here's a functional framework you can adapt:

[COMPANY NAME]

Position: Chief Medical Officer

Reports To: Chief Executive Officer

Location: Boston, MA (or other hub)

The Opportunity

[Company name] is a clinical-stage biotech company developing [disease area] therapeutics. We are seeking an experienced Chief Medical Officer to lead clinical strategy, regulatory affairs partnership, and medical affairs for our pipeline of [number] programs currently in [phases]. This is a hands-on role; you will own the clinical development plan, lead FDA interactions, and build the medical affairs function from the ground up.

Core Responsibilities

• Own the clinical development strategy across all programs; define trial designs, endpoints, and regulatory pathways for each indication.
• Lead preparation and execution of IND and NDA/BLA submissions; conduct pre-submission meetings with FDA.
• Build and scale the medical affairs function, including medical information, speaker programs, and KOL engagement.
• Establish pharmacovigilance systems and ensure rigorous adverse event monitoring.
• Partner with CMO on translational science strategy; partner with Head of Regulatory on submission planning.
• Report quarterly to the Board on clinical progress, regulatory strategy, and competitive positioning.

Required Qualifications

• MD, DO, or equivalent (DVM, PhD + significant pharma experience considered on case-by-case basis).
• 12+ years of progressive leadership in biotech or pharma, including at least 5 years as a Medical Director or CMO.
• Demonstrated success leading clinical trials to completion; evidence of clinical leadership (publications, conference presentations).
• Hands-on experience with FDA submissions (IND, NDA/BLA); familiarity with Breakthrough, Fast Track, or Accelerated Approval programs.
• Ability to build, mentor, and scale teams in a resource-constrained environment.

Excellent communication skills; ability to articulate medical strategy to non-clinical stakeholders.

Preferred Qualifications

• Prior experience in [specific disease area].
• Published clinical research or evidence of KOL relationships.
• Experience in [your company's therapeutic modality — e.g., RNA, gene therapy, cell therapy].
• International regulatory experience (EMA, PMDA, Health Canada).

Compensation & Benefits

• Base salary: $[range]
• Performance bonus: [percentage] of base, tied to regulatory and clinical milestones
• Equity: [options/RSUs], 4-year vest, 1-year cliff
• Comprehensive health benefits, 401(k), flexible work arrangements

Notice the specificity: disease area, therapeutic modality, program count, reporting line, and quantified KPIs. This prevents ambiguity and attracts candidates who fit the specific role, not the vague idea of a "CMO."

Medical Officer Executive Recruitment: The Search Process

Recruiting a Chief Medical Officer is different from recruiting a VP Sales or CFO. Medical credibility is crucial. Here's how to structure the search:

Stage 1: Define the Profile

Before engaging a recruiter or posting the role, your team (CEO, Chief Scientific Officer, Head of Regulatory) should align on exactly what you need. Use the Chief Medical Officer job description as a starting point, but dig deeper:

• Disease area expertise: How critical is deep oncology or cardiology experience versus general pharma acumen?
• Stage experience: Do you need someone who's built medical affairs from scratch (early-stage) or someone who can scale existing infrastructure (late-stage)?
• Regulatory flavor: FDA-only, or international experience required?
• Commercial fluency: How involved should the CMO be in pricing/reimbursement strategy?

Write these answers down. Share them with recruiters. They'll screen candidates more effectively.

Stage 2: Sourcing

CMOs are typically passive candidates. They're already employed and not scrolling LinkedIn job boards. Effective sourcing involves:

Executive search firms: A retained search firm with healthcare expertise can identify and approach passive candidates. Expect to pay 30–35% of the first-year compensation as a fee. This is the standard model for executive search at the CMO and C-suite level.

KOL networks: Ask your Board members, advisors, and KOLs if they know candidates. Personal referrals are gold.

Competitive intelligence: Who is the CMO at your competitor's company? Are they happy? Could they move?

Academic medical centers: Senior physician-scientists at major medical centers (Mayo, Cleveland Clinic, UCSF) sometimes transition to industry. A targeted outreach can yield strong candidates.

Stage 3: Interview Process

Structure the interview to assess both clinical and executive competence:

Round 1 (Recruiter/HR screening): Verify credentials, confirm interest, and assess compensation fit. Ask: "Walk me through your clinical development experience. Tell me about a program you led from Phase 1 to approval." Listen for specificity.

Round 2 (CEO/Chief Scientific Officer): Medical strategy assessment. Ask scenario-based questions: "You're running a Phase 2b trial in [indication]. Interim data show promising efficacy but an unexpected safety signal. Walk me through your decision-making." Candidates who think step-by-step, consulting regulators early, are more mature than those who jump to "Stop the trial."

Round 3 (Head of Regulatory, Board member): Assess regulatory judgment and external credibility. Ask: "Tell me about a pre-submission meeting with FDA that surprised you. How did you respond?" Look for candidates who view FDA as a partner, not an adversary.

Round 4 (Reference calls): Speak with the candidate's prior CEO, their Head of Regulatory Affairs, and a peer CMO or Chief Scientific Officer. Ask specifically: "What was this person's impact on clinical timelines? On regulatory strategy? On building teams? Where would you coach them to improve?"

Building a Medical Affairs Function That Supports Your CMO

The CMO job description often includes "build and lead medical affairs," but many hiring managers underestimate how much organizational infrastructure that requires. A functional medical affairs team includes:

• Medical Information Specialist: Responds to unsolicited medical inquiries, maintains medical literature databases, prepares safety reports.
• Medical Affairs Manager: Oversees speaker programs, scientific meeting presence, publication strategy, and HCP education.
• Medical Liaison (if commercial stage): Field-based representative who speaks to physicians, gathers real-world data, and educates on proper use.

Health Economics/Market Access Manager: Supports payer discussions, health economics modeling, and reimbursement strategy.

A new CMO should not be left to hire and build this function alone, especially at early stage. The CEO should allocate budget ($500K–$1M+), give the CMO recruiting support, and set clear timelines for team build-out.

Regulatory Strategy & CMO Alignment: FDA Pathways

One of the most critical responsibilities in the Chief Medical Officer job description is translating clinical data into regulatory strategy. This requires deep FDA knowledge.

The CMO should be fluent in:

• Standard approval pathway: Traditional IND-Phase 1-2-3-NDA/BLA timeline (typically 6–8 years). When is this appropriate? When your data are solid but unexceptional.
• Breakthrough Therapy Designation: FDA's program for drugs that demonstrate substantial improvement over existing treatments. Allows expedited review timelines and frequent interaction with FDA. Candidates should be able to articulate when Breakthrough is appropriate and how to prepare the submission package.
• Fast Track Designation: Similar to Breakthrough but for serious unmet medical needs. Less expedited than Breakthrough but offers priority review.
• Accelerated Approval: Allows approval based on surrogate endpoints, with post-approval commitments to confirm clinical benefit. Used heavily in oncology and rare disease. A CMO must understand surrogate endpoint validation and post-approval trial obligations.
• Conditional Approval (EU) / Orphan Designation (US/EU): For rare diseases, designated therapies get expedited review, orphan tax credits, and market exclusivity. The CMO should know when to file for orphan status and how that affects development timelines.

During the interview, ask candidates: "Tell me about a program where you sought Breakthrough designation. Was it appropriate? What was the outcome?" Vague answers suggest the candidate hasn't owned this decision.

How Do You Hire a CMO When You're a Foreign-Owned Company?

If your company is foreign-owned — headquartered in Basel, Cambridge (UK), Tokyo, or Singapore — but expanding to the US, the CMO role gains complexity. The US CMO must bridge the parent company's medical strategy and FDA expectations.

Key considerations when writing the Chief Medical Officer job description:

1. Clarify reporting structure. Does the CMO report to the US subsidiary CEO or dotted-line to the parent company's Chief Medical Officer? Most mature setups use both: primary to the US CEO for accountability, dotted-line to the global CMO for strategic alignment.
2. Specify global involvement. Will the CMO participate in global development planning? Have input on EMA submissions? Lead US-specific safety monitoring that feeds global pharmacovigilance? Be explicit.
3. Clarify medical affairs scope. Is the US CMO building a US-only medical affairs function or integrating with the parent company's global medical team? This affects hiring timelines and budget.
4. Address regulatory differences. FDA approval timelines and data requirements differ from EMA and PMDA. The CMO must be able to explain these differences to the parent company and advocate for US-appropriate clinical development strategies.

When recruiting through executive search or US expansion hiring channels, emphasize these nuances. Candidates who've successfully navigated the US market for a foreign parent company are rare and valuable.

Retention & Development: Keeping Your CMO Engaged

CMO retention is often overlooked. A frustrated CMO leaves, and you lose continuity on your most critical regulatory relationships and clinical decisions.

Strategies to retain your CMO:

• Clarity on long-term role. Early on, discuss where the CMO fits as the company scales. Will the CMO become Chief Development Officer? Transition to Board advisor? This prevents the sense that the role becomes vestigial as the company matures.
• Professional development. Support CMO participation in medical conferences, advisory boards, and publication opportunities. These activities keep the CMO credible in the field and engaged intellectually.
• Peer networks. Connect your CMO with peer CMOs at other biotech companies. Peer advisory groups, often convened through industry associations, reduce isolation and provide sounding board support.
• Equity refresh. If the company is performing well, consider equity refreshes or retention bonuses after the first 3–4 years. This prevents the CMO from watching dilution without upside adjustment.
• Transparent communication on company trajectory. If the company is struggling or facing a pivot, involve the CMO early. CMOs who learn about major strategy shifts from the board meeting notes feel blindsided and often leave.

When Should You Hire a Full-Time CMO vs. a Consultant?

Not every company needs a full-time CMO from day one. Very early-stage companies (seed/Series A) might retain a fractional or consultant CMO — a part-time advisor with deep expertise who reviews the clinical development plan, attends key FDA meetings, and mentors the team.

A fractional CMO typically costs $10,000–$30,000/month and provides 10–20 hours/week of work. This is a cost-effective approach for companies that don't yet have the budget or volume of work for a full-time hire.

However, fractional arrangements have limits. Fractional CMOs rarely build medical affairs teams, often have competing priorities at other companies, and don't develop deep institutional knowledge. As soon as you have multiple clinical programs or are approaching FDA submissions, you need a full-time CMO.

Use the Chief Medical Officer job description to trigger the decision: if the role requires presence at daily standups, leadership of team hires, and visible relationship-building with FDA, it's a full-time role.

Conclusion: From Description to Right Hire

The Chief Medical Officer job description is your blueprint for one of the most impactful hires a biotech company can make. A strong CMO accelerates clinical timelines, builds credibility with regulators, and translates science into strategy. A weak CMO misses regulatory windows, alienates KOLs, and sows doubt about the company's medical judgment.

Write the role description with specificity. Define the disease area, the pipeline state, the regulatory priorities, and the expected scope of medical affairs. Screen for candidates with hands-on FDA experience, published clinical data, and evidence of team-building capability. Assess not just credentials but judgment, resilience, and ability to operate under uncertainty.

Pact & Partners is a boutique executive search firm — founded in 1987 — that helps foreign companies of all sectors recruit executive talent. Since 2006, we have focused on placing executives for US operations. Thousands of placements for hundreds of clients from 30+ countries. Headquartered in Miami, with a second office in Boston. Our experience placing CMOs at biotech subsidiaries and JVs has taught us that the difference between a hire that works and one that flounders often comes down to role clarity and fit. Whether you're seeking a CEO or General Manager, the principles of clear role definition apply. If you're hiring a CMO for the US market — whether you're based in Boston, Basel, or Singapore — we can help you source, screen, and close candidates who understand both your company's medical strategy and FDA realities.CEOGeneral Manager

The right CMO sets the tone for how your company translates science into evidence, evidence into regulatory strategy, and strategy into patient impact. Don't settle for a credential. Invest in clarity, rigor, and fit.